ATE66375T1 - USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES. - Google Patents

USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.

Info

Publication number
ATE66375T1
ATE66375T1 AT85111184T AT85111184T ATE66375T1 AT E66375 T1 ATE66375 T1 AT E66375T1 AT 85111184 T AT85111184 T AT 85111184T AT 85111184 T AT85111184 T AT 85111184T AT E66375 T1 ATE66375 T1 AT E66375T1
Authority
AT
Austria
Prior art keywords
gamma
interferon
ifn
low doses
human diseases
Prior art date
Application number
AT85111184T
Other languages
German (de)
Inventor
Josef Dr Brzoska
Johann-Friedrich Von Eichborn
Hans-Joachim Dr Obert
Original Assignee
Bioferon Biochem Substanz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843436637 external-priority patent/DE3436637A1/en
Priority claimed from DE3436638A external-priority patent/DE3436638C2/en
Priority claimed from DE19853521733 external-priority patent/DE3521733A1/en
Application filed by Bioferon Biochem Substanz filed Critical Bioferon Biochem Substanz
Priority claimed from EP85111184A external-priority patent/EP0181455B2/en
Application granted granted Critical
Publication of ATE66375T1 publication Critical patent/ATE66375T1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a γ-interferon preparation for treating neoplastic or neoblastic cell proliferation, particularly epinephroma. SOLUTION: This is the composition which contains human γ-interferon as an active ingredient and is administrated at intervals of days or months. The daily dose to the adult patient who weighs about 60 kg and has body surface area of 1.7 m<2> contains the above active ingredient in an amount of 100,000-2,000,000 international standard units.
AT85111184T 1984-10-05 1985-09-04 USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES. ATE66375T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19843436637 DE3436637A1 (en) 1984-10-05 1984-10-05 Use of interferon-gamma (IFN-gamma)-containing preparations for the treatment of pain
DE3436638A DE3436638C2 (en) 1984-10-05 1984-10-05 Use of preparations containing interferon-gamma (IFN-gamma) for the treatment of rheumatic diseases
DE19853521733 DE3521733A1 (en) 1985-06-18 1985-06-18 Use of preparations containing interferon-gamma (IFN-gamma) for the systemic treatment of tumours and viral diseases in low dosage
EP85111184A EP0181455B2 (en) 1984-10-05 1985-09-04 Use of preparations containing interferon-gamma (IFN-gamma) for systematically treating various human diseases at a low dosage

Publications (1)

Publication Number Publication Date
ATE66375T1 true ATE66375T1 (en) 1991-09-15

Family

ID=27433212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85111184T ATE66375T1 (en) 1984-10-05 1985-09-04 USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.

Country Status (2)

Country Link
JP (3) JP2662214B2 (en)
AT (1) ATE66375T1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon
JP2850293B2 (en) * 1996-10-25 1999-01-27 株式会社林原生物化学研究所 γ-interferon sensitive disease agent
US7273888B2 (en) * 2001-11-16 2007-09-25 Als Therapy Development Foundation, Inc. Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis
JP2004166847A (en) * 2002-11-18 2004-06-17 Otsuka Pharmaceut Factory Inc Infusion mixing device, mixing tube, chemical solution container, mixed solution container, infusion formulation system, and infusion formulation method
GB0526552D0 (en) * 2005-12-29 2006-02-08 Morvus Technology Ltd New use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
EP0080032A3 (en) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions
JPS59175416A (en) * 1983-03-25 1984-10-04 Sunstar Inc External preparation for remedy of keratonosis of skin and mucosa

Also Published As

Publication number Publication date
JPH1087506A (en) 1998-04-07
JP3048533B2 (en) 2000-06-05
JPH11255665A (en) 1999-09-21
JPS6193130A (en) 1986-05-12
JP2662214B2 (en) 1997-10-08

Similar Documents

Publication Publication Date Title
DE3583849D1 (en) USE OF INTERFERON GAMMA (IFN-GAMMA) CONTAINERS FOR THE SYSTEMIC TREATMENT OF VARIOUS DISEASES OF HUMAN IN LOW DOSAGE.
ATE73331T1 (en) USE OF TETRAHYDROBIOPTERINS TO MANUFACTURE A MEDICATION FOR THE TREATMENT OF CHILDREN&#39;S AUTISM.
ATE157251T1 (en) USE OF INOSITOL TRIPHOSPHATE TO TREAT INFLAMMATION
NZ215939A (en) Phosphonyl methoxyadenine antiviral compositions
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
DE69333321D1 (en) Use of a consensus interferon to reduce the side effects in the interferon treatment of viral hepatites.
ATE227587T1 (en) COMBINED USE OF HYALURONIC ACID AND THERAPEUTIC ACTIVE INGREDIENTS TO IMPROVE THE THERAPEUTIC EFFECT
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
EP0151989A3 (en) Means for the treatment of cardiac diseases
DE3680368D1 (en) BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIE FACTOR, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS.
ATE55695T1 (en) USE OF DEFIBROTIDE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES.
ATE81984T1 (en) USE OF GRANULOCYTE MACROPHAGE COLONY EXCITING FACTOR IN THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF BACTERIAL DISEASES.
ES8102141A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
EP0253146A3 (en) The use of d-fenfluramine for the manufacture of medicaments for treating depression
ATE66375T1 (en) USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.
DE69129563D1 (en) Epidermal growth factor as a medicine to restore the substantia nigra neurons in the treatment of nerve-destroying disorders
IE45054L (en) Veterinary composition
KR100271087B1 (en) Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
JPS6483020A (en) Medicinal composition for preventing or treating aids
MY104124A (en) Therapeutic compounds.
ES8205190A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
ATE141510T1 (en) MEDICINAL PRODUCTS CONTAINING CD14
ATE87482T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CEREBRAL PSYCHO-ORGANIC SYNDROMES.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time